1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Patología Molecular del Cáncer

Patología Molecular del Cáncer

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Pinto-Díez C, García-Recio EM, Pérez-Morgado MI, García-Hernández M, Sanz-Criado L, Sacristán S, Toledo-Lobo MV, Pérez-Mies B, Esteban-Rodríguez I, Pascual A, Garcia-Villanueva M, Martínez-Jañez N, González VM, Martín ME.

    Increased expression of MNK1b, the spliced isoform of MNK1, predicts poor prognosis and is associated with triple-negative breast cancer.

    Oncotarget . 9(17): 13501-13516.

    [doi:10.18632/oncotarget.24417]

  • Oaknin A, Guarch R, Barretina P, Hardisson D, González-Martín A, Matías-Guiu X, Pérez-Fidalgo A, Vieites B, Romero I, Palacios J.

    Erratum to: Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

    CLINICAL & TRANSLATIONAL ONCOLOGY . 20(3): 424-424. Nº de citas: 1

    [doi:10.1007/s12094-017-1746-7]

  • Burgués O, López-García MÁ, Pérez-Míes B, Santiago P, Vieites B, García JF, Peg V.

    The ever-evolving role of pathologists in the management of breast cancer with neoadjuvant treatment: recommendations based on the Spanish clinical experience.

    CLINICAL & TRANSLATIONAL ONCOLOGY . 20(3): 382-391. Nº de citas: 2

    [doi:10.1007/s12094-017-1725-z]

  • Oaknin A, Guarch R, Barretina P, Hardisson D, González A, Matías-Guiu X, Pérez-Fidalgo A, Vieites B, Romero I, Palacios J.

    Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

    CLINICAL & TRANSLATIONAL ONCOLOGY . 20(3): 274-285. Nº de citas: 5

    [doi:10.1007/s12094-017-1719-x]

  • Espinosa I, De Leo A, D'Angelo E, Rosa-Rosa JM, Corominas M, Gonzalez A, Palacios J, Prat J.

    Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study.

    HUMAN PATHOLOGY . 72: 100-106. Nº de citas: 20

    [doi:10.1016/j.humpath.2017.11.006]

  • Ovarian Tumor Tissue Analysis (OTTA) Consortium, Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W, Fogarty ZC, Gentry-Maharaj A, Toloczko A, Hein A, Bouligny AL, Jensen A, Osorio A, Hartkopf AD, Ryan A, Chudecka-Glaz A, Magliocco AM, Hartmann A, Jung AY, Gao B, Hernandez BY, Fridley BL, McCauley BM, Kennedy CJ, Wang C, Karpinskyj C, de Sousa CB, Tiezzi DG, Wachter DL, Herpel E, Taran FA, Modugno F, Nelson G, Lubinski J, Menkiszak J, Alsop J, Lester J, García-Donas J, Nation J, Hung J, Palacios J, Rothstein JH, Kelley JL, de Andrade JM, Robles-Díaz L, Intermaggio MP, Widschwendter M, Beckmann MW, Ruebner M, Jimenez-Linan M, Singh N, Oszurek O, Harnett PR, Rambau PF, Sinn P, Wagner P, Ghatage P, Sharma R, Edwards RP, Ness RB, Orsulic S, Brucker SY, Johnatty SE, Longacre TA, Eilber U, McGuire V, Sieh W, Natanzon Y, Li Z, Whittemore AS, deFazio A, Staebler A, Karlan BY, Gilks B, Bowtell DD, Høgdall E, Candido Dos Reis FJ, Steed H, Campbell IG, Gronwald J, Benítez J, Koziak JM, Chang-Claude J, Moysich KB, Kelemen LE, Cook LS, Goodman MT, García MJ, Fasching PA, Kommoss S, Deen S, Kjaer SK, Menon U, Brenton JD, Pharoah PDP, Chenevix-Trench G, Huntsman DG, Winham SJ, Köbel M, Ramus SJ.

    Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

    JAMA Oncology . 3(12): .

    [doi:10.1001/jamaoncol.2017.3290]

  • Gómez-Mariscal M, Oleñik A, Arriba-Palomero P, García-Cosio M, Muñoz-Negrete FJ.

    Recurrent Bilateral Anterior Uveitis with Kikuchi-Fujimoto Disease.

    OCULAR IMMUNOLOGY AND INFLAMMATION . 25(6): 866-869. Nº de citas: 3

    [doi:10.1080/09273948.2016.1188966]

  • Garrido P, Aldaz A, Calleja MÁ, De Álava E, Lamas MJ, Martín M, Matías-Guiu X, Palacios J, Vera R.

    Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: a position statement of SEOM, SEAP and SEFH.

    FARMACIA HOSPITALARIA . 41(6): 688-691.

    [doi:10.7399/fh.10877]

  • Martín M, Chacón JI, Antón A, Plazaola A, García-Martínez E, Seguí MA, Sánchez-Rovira P, Palacios J, Calvo L, Esteban C, Espinosa E, Barnadas A, Batista N, Guerrero A, Muñoz M, Romio E, Rodríguez-Martín C, Caballero R, Casas MI, Rojo F, Carrasco E, Antolín S.

    Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis.

    ONCOLOGIST . 22(11): 1301-1308. Nº de citas: 9

    [doi:10.1634/theoncologist.2017-0052]

  • Gayarre J, Martín-Gimeno P, Osorio A, Paumard B, Barroso A, Fernández V, de la Hoya M, Rojo A, Caldés T, Palacios J, Urioste M, Benítez J, García MJ.

    Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes.

    BRITISH JOURNAL OF CANCER . 117(7): 1048-1062. Nº de citas: 6

    [doi:10.1038/bjc.2017.286]

  • Garrido P, Olmedo ME, Gómez A, Paz Ares L, López-Ríos F, Rosa-Rosa JM, Palacios J.

    Treating KRAS -mutant NSCLC: latest evidence and clinical consequences.

    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY . 9(9): 589-597. Nº de citas: 26

    [doi:10.1177/1758834017719829]

  • Espinosa I, Lee CH, D'Angelo E, Palacios J, Prat J.

    Undifferentiated and Dedifferentiated Endometrial Carcinomas With POLE Exonuclease Domain Mutations Have a Favorable Prognosis.

    The American journal of surgical pathology . 41(8): 1121-1128. Nº de citas: 49

    [doi:10.1097/PAS.0000000000000873]

  • Vaca M, Polo R, Martínez-San-Millán J, Reguero ME, Pérez C, Cordero A, Medina MD, Cobeta I.

    Pigmented Villonodular Synovitis of the Temporomandibular Joint With Petrous Bone Invasion.

    OTOLOGY & NEUROTOLOGY . 38(5): . Nº de citas: 3

    [doi:10.1097/MAO.0000000000001390]

  • Quintela-Fandino M, Lluch A, Manso LM, Calvo I, Cortes J, García-Saenz JA, Gil JM, Martinez-Jañez N, González-Martín A, Adrover E, De Andres R, Viñas G, Llombart Cussac A, Alba E, Guerra J, Bermejo B, Zamora E, Moreno-Anton F, Pernas-Simon S, Carrato A, Lopez A, Escudero MJ, Campo R, Carrasco EM, Palacios J, Mulero F, Colomer R.

    18F-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized Trial.

    Clinical cancer research : an official journal of the American Association for Cancer Research . 23(6): 1432-1441. Nº de citas: 21

    [doi:10.1158/1078-0432.CCR-16-0738]

  • Devis L, Moiola CP, Masia N, Martinez-Garcia E, Santacana M, Stirbat TV, Brochard-Wyart F, García Á, Alameda F, Cabrera S, Palacios J, Moreno-Bueno G, Abal M, Thomas W, Dufour S, Matias-Guiu X, Santamaria A, Reventos J, Gil-Moreno A, Colas E.

    Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.

    JOURNAL OF PATHOLOGY . 241(4): 475-487. Nº de citas: 32

    [doi:10.1002/path.4851]

  • Vaz Salgado MA, Soto M, Reguero ME, Muñoz G, Cabañero A, Gallego I, Resano S, Longo F, Madariaga A, Gomez A, Carrato A.

    Clinical behavior of solitary fibrous tumor: a retrospective review of 30 patients.

    CLINICAL & TRANSLATIONAL ONCOLOGY . 19(3): 357-363. Nº de citas: 7

    [doi:10.1007/s12094-016-1536-7]

  • Martínez-Iglesias O, Olmeda D, Alonso-Merino E, Gómez-Rey S, González-López AM, Luengo E, Soengas MS, Palacios J, Regadera J, Aranda A.

    The nuclear corepressor 1 and the thyroid hormone receptor ß suppress breast tumor lymphangiogenesis.

    Oncotarget . 7(48): 78971-78984. Nº de citas: 1

    [doi:10.18632/oncotarget.12978]

  • Rosa-Rosa JM, Leskelä S, Cristóbal-Lana E, Santón A, López-García MÁ, Muñoz G, Pérez-Mies B, Biscuola M, Prat J, Esther OE, Soslow RA, Matias-Guiu X, Palacios J.

    Molecular genetic heterogeneity in undifferentiated endometrial carcinomas.

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc . 29(11): 1390-1398. Nº de citas: 47

    [doi:10.1038/modpathol.2016.132]